Pregnancy outcome in women with sickle cell disease/trait in a tertiary care hospital Nagpur, Maharashtra India: a descriptive cross sectional study

Authors

  • Varsha Kose Department of Obstetrics and Gynecology, N. K. P. Salve Institute of Medical Sciences and Research Centre, Digdoh Hills, Hingna Road, Nagpur, Maharashtra, India
  • Saurabh Kose Intern, N.K.P. Salve Institute of Medical Sciences and Research Centre, Nagpur, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20194359

Keywords:

Maternal morbidity, Perinatal outcome, Sickle cell disease

Abstract

Background: Pregnancy in sickle cell women has numerous obstetrical, nonobstetrical and fetal complications. Our objective was to study the pregnancy outcome in women with sickle cell disease/trait.

Methods: A descriptive cross sectional study in 2 years study period was conducted. 57 women with sickle cell disease/trait were identified. They were attending the antenatal clinic and were admitted in obstetric ward and followed till 7 days after delivery.

Results: Out of total 57 women 49 women (85.96%) were sickle cell trait (AS pattern) and 8 women (14.03%) were sickle cell disease (SS pattern). In women with sickle cell trait Pregnancy induced hypertension was the most common complication. Anaemia and hypothyroidism was the common associated medical problem. 5 babies need NICU admission, 6 babies PBU admission and 33 babies given to mother side just after birth. In women with sickle cell disease severe anaemia, preeclampsia, oligohydramnios and intrauterine growth restriction, lower segment caesarean section for preterm baby was the most common complication. 1 baby required NICU admission, 5 babies require PBU admission and only 2 babies given to mother just after delivery. There were no maternal mortality and neonatal mortality.

Conclusions: Maternal morbidity and neonatal morbidity is more in sickle cell disease women. They require early diagnosis, premarital and preconceptional counselling, good multidisciplinary obstetrics and neonatal care and early referral to higher centre.

Author Biography

Varsha Kose, Department of Obstetrics and Gynecology, N. K. P. Salve Institute of Medical Sciences and Research Centre, Digdoh Hills, Hingna Road, Nagpur, Maharashtra, India



References

D’Couth S, Kalam S. Fetomaternal outcome in sickle cell hemoglobinopathy in a tertiary care centre of north Kerala, India. Int J Repro Contra Obstet Gynecol. 2017;6(12):5299-305.

Sonwane A, Zodpey S. Pregnancy outcome in women with sickle cell disease/trait. The Journal of Obstetrics and Gynecology of India. 2005;55(5):415-8.

Desai G, Anand A. Sickle cell disease and pregnancy outcomes: a study of the community - based hospital in a tribal block of Gujarat, India. J Health Populat Nutrit. 2017;3(36):1-13.

Muganyizi P, Kdanto H. Sickle cell disease in pregnancy: Trend and pregnancy outcomes at a tertiary Hospital in Tanzania. PLOS One. 2013:1-7.

Wilson NO, Ceesay FK. Pregnancy outcome among patients. Am J Trop Med Hyg. 2012;86(6):936-42.

Elenga N, Adeline A. Pregnancy in sickle cell disease is a very high risk situation: an observational study. Obstet Gynaecol Int J. 2016:1-5.

Mulla-Ali DH, Kuo KHM. The relationship between pregnancy, sickle cell disease specific complication and maternal and fetal outcome in sickle cell disease. Blood. 2011;118:1-3.

Kahansim ML, Ocheke AN. Pregnancy outcome among patients with sickle cell disease in Jos North central Nigeria, Jos J Med. 2014;8(3):9-13.

Anhita C, Madhva P. Outcome of pregnancy with haemoglobinopathy in a tertiary care centre. J Obstet Gynaecol India. 2018;68(5):394-9.

Downloads

Published

2019-09-26

Issue

Section

Original Research Articles